Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Omics-based Identification of Glycan Structures as Biomarkers for a Variety of Diseases.

Akiyoshi S, Iwata M, Berenger F, Yamanishi Y.

Mol Inform. 2019 Oct 17. doi: 10.1002/minf.201900112. [Epub ahead of print]

PMID:
31622036
2.

Predicting drug-induced transcriptome responses of a wide range of human cell lines by a novel tensor-train decomposition algorithm.

Iwata M, Yuan L, Zhao Q, Tabei Y, Berenger F, Sawada R, Akiyoshi S, Hamano M, Yamanishi Y.

Bioinformatics. 2019 Jul 15;35(14):i191-i199. doi: 10.1093/bioinformatics/btz313.

3.

Pathway-Based Drug Repositioning for Cancers: Computational Prediction and Experimental Validation.

Iwata M, Hirose L, Kohara H, Liao J, Sawada R, Akiyoshi S, Tani K, Yamanishi Y.

J Med Chem. 2018 Nov 8;61(21):9583-9595. doi: 10.1021/acs.jmedchem.8b01044. Epub 2018 Oct 29.

PMID:
30371064
4.

CD44v9 as a poor prognostic factor of triple-negative breast cancer treated with neoadjuvant chemotherapy.

Tokunaga E, Fujita A, Takizawa K, Baba K, Akiyoshi S, Nakamura Y, Ijichi H, Masuda T, Koga C, Tajiri W, Ohno S, Taguchi K, Ishida M.

Breast Cancer. 2019 Jan;26(1):47-57. doi: 10.1007/s12282-018-0888-y. Epub 2018 Jul 3.

5.

Impact of Visceral Metastasis on Efficacy of Fulvestrant in Patients with Hormone Receptor-positive Recurrent Breast Cancer.

Koi Y, Koga C, Akiyoshi S, Masuda T, Ijichi H, Nakamura Y, Ishida M, Ohno S, Tokunaga E.

Anticancer Res. 2018 Mar;38(3):1579-1584.

PMID:
29491088
6.

Subpopulations of vomeronasal sensory neurons with coordinated coexpression of type 2 vomeronasal receptor genes are differentially dependent on Vmn2r1.

Akiyoshi S, Ishii T, Bai Z, Mombaerts P.

Eur J Neurosci. 2018 Apr;47(7):887-900. doi: 10.1111/ejn.13875. Epub 2018 Mar 25.

7.

Relationship between bovine endometrial thickness and plasma progesterone and estradiol concentrations in natural and induced estrus.

Sugiura T, Akiyoshi S, Inoue F, Yanagawa Y, Moriyoshi M, Tajima M, Katagiri S.

J Reprod Dev. 2018 Apr 13;64(2):135-143. doi: 10.1262/jrd.2017-139. Epub 2018 Feb 3.

8.

Cytogenetic analysis of metaplastic squamous cell carcinoma of the breast inter- and intratumoral heterogeneity.

Oikawa M, Igawa A, Taguchi K, Baba K, Ishida M, Akiyoshi S, Yano H, Nagayasu T, Ohno S, Tokunaga E.

Breast Cancer. 2017 Nov;24(6):733-741. doi: 10.1007/s12282-017-0768-x. Epub 2017 Mar 18.

PMID:
28316008
9.

Chemotherapy-induced amenorrhea and the resumption of menstruation in premenopausal women with hormone receptor-positive early breast cancer.

Koga C, Akiyoshi S, Ishida M, Nakamura Y, Ohno S, Tokunaga E.

Breast Cancer. 2017 Sep;24(5):714-719. doi: 10.1007/s12282-017-0764-1. Epub 2017 Feb 27.

PMID:
28243992
10.

Expression of APOBEC3B mRNA in Primary Breast Cancer of Japanese Women.

Tokunaga E, Yamashita N, Tanaka K, Inoue Y, Akiyoshi S, Saeki H, Oki E, Kitao H, Maehara Y.

PLoS One. 2016 Dec 15;11(12):e0168090. doi: 10.1371/journal.pone.0168090. eCollection 2016.

11.

Rapid diagnosis of lymph node metastasis in breast cancer using a new fluorescent method with γ-glutamyl hydroxymethyl rhodamine green.

Shinden Y, Ueo H, Tobo T, Gamachi A, Utou M, Komatsu H, Nambara S, Saito T, Ueda M, Hirata H, Sakimura S, Takano Y, Uchi R, Kurashige J, Akiyoshi S, Iguchi T, Eguchi H, Sugimachi K, Kubota Y, Kai Y, Shibuta K, Kijima Y, Yoshinaka H, Natsugoe S, Mori M, Maehara Y, Sakabe M, Kamiya M, Kakareka JW, Pohida TJ, Choyke PL, Kobayashi H, Ueo H, Urano Y, Mimori K.

Sci Rep. 2016 Jun 9;6:27525. doi: 10.1038/srep27525.

12.

Noise-driven growth rate gain in clonal cellular populations.

Hashimoto M, Nozoe T, Nakaoka H, Okura R, Akiyoshi S, Kaneko K, Kussell E, Wakamoto Y.

Proc Natl Acad Sci U S A. 2016 Mar 22;113(12):3251-6. doi: 10.1073/pnas.1519412113. Epub 2016 Mar 7.

13.

[Academic achievement of children born with very low birth weights at the age of 10 years].

Nagao H, Iwanaga M, Akiyoshi S.

No To Hattatsu. 2015 Jul;47(4):279-82. Japanese.

PMID:
26353449
14.

Epigenetic Inactivation of BRCA1 Through Promoter Hypermethylation and Its Clinical Importance in Triple-Negative Breast Cancer.

Yamashita N, Tokunaga E, Kitao H, Hitchins M, Inoue Y, Tanaka K, Hisamatsu Y, Taketani K, Akiyoshi S, Okada S, Oda Y, Saeki H, Oki E, Maehara Y.

Clin Breast Cancer. 2015 Dec;15(6):498-504. doi: 10.1016/j.clbc.2015.06.009. Epub 2015 Jun 18.

PMID:
26195437
15.

miR-29b is an indicator of prognosis in breast cancer patients.

Shinden Y, Iguchi T, Akiyoshi S, Ueo H, Ueda M, Hirata H, Sakimura S, Uchi R, Takano Y, Eguchi H, Sugimachi K, Kijima Y, Natsugoe S, Mimori K.

Mol Clin Oncol. 2015 Jul;3(4):919-923. Epub 2015 May 12.

16.

Rapid intraoperative visualization of breast lesions with γ-glutamyl hydroxymethyl rhodamine green.

Ueo H, Shinden Y, Tobo T, Gamachi A, Udo M, Komatsu H, Nambara S, Saito T, Ueda M, Hirata H, Sakimura S, Takano Y, Uchi R, Kurashige J, Akiyoshi S, Iguchi T, Eguchi H, Sugimachi K, Kubota Y, Kai Y, Shibuta K, Kijima Y, Yoshinaka H, Natsugoe S, Mori M, Maehara Y, Sakabe M, Kamiya M, Kakareka JW, Pohida TJ, Choyke PL, Kobayashi H, Ueo H, Urano Y, Mimori K.

Sci Rep. 2015 Jul 13;5:12080. doi: 10.1038/srep12080.

17.

F-box protein FBXW7 inhibits cancer metastasis in a non-cell-autonomous manner.

Yumimoto K, Akiyoshi S, Ueo H, Sagara Y, Onoyama I, Ueo H, Ohno S, Mori M, Mimori K, Nakayama KI.

J Clin Invest. 2015 Feb;125(2):621-35. doi: 10.1172/JCI78782. Epub 2015 Jan 2.

18.

Diminished expression of MiR-15a is an independent prognostic marker for breast cancer cases.

Shinden Y, Akiyoshi S, Ueo H, Nambara S, Saito T, Komatsu H, Ueda M, Hirata H, Sakimura S, Uchi R, Takano Y, Iguchi T, Eguchi H, Sugimachi K, Kijima Y, Ueo H, Natsugoe S, Mimori K.

Anticancer Res. 2015 Jan;35(1):123-7.

PMID:
25550542
19.

Spontaneous regression of breast cancer with axillary lymph node metastasis: a case report and review of literature.

Tokunaga E, Okano S, Nakashima Y, Yamashita N, Tanaka K, Akiyoshi S, Taketani K, Shirouzu M, Yamamoto H, Morita M, Maehara Y.

Int J Clin Exp Pathol. 2014 Jun 15;7(7):4371-80. eCollection 2014. Review.

20.

RNAi screening of human glycogene orthologs in the nematode Caenorhabditis elegans and the construction of the C. elegans glycogene database.

Akiyoshi S, Nomura KH, Dejima K, Murata D, Matsuda A, Kanaki N, Takaki T, Mihara H, Nagaishi T, Furukawa S, Ando KG, Yoshina S, Mitani S, Togayachi A, Suzuki Y, Shikanai T, Narimatsu H, Nomura K.

Glycobiology. 2015 Jan;25(1):8-20. doi: 10.1093/glycob/cwu080. Epub 2014 Aug 4.

21.

A family of nonclassical class I MHC genes contributes to ultrasensitive chemodetection by mouse vomeronasal sensory neurons.

Leinders-Zufall T, Ishii T, Chamero P, Hendrix P, Oboti L, Schmid A, Kircher S, Pyrski M, Akiyoshi S, Khan M, Vaes E, Zufall F, Mombaerts P.

J Neurosci. 2014 Apr 9;34(15):5121-33. doi: 10.1523/JNEUROSCI.0186-14.2014.

22.

A case of invasive micropapillary carcinoma of the breast involving extensive lymph node metastasis.

Taketani K, Tokunaga E, Yamashita N, Tanaka K, Zaitsu Y, Akiyoshi S, Okada S, Aishima S, Morita M, Maehara Y.

World J Surg Oncol. 2014 Apr 4;12:84. doi: 10.1186/1477-7819-12-84.

23.

Impact of GATA-3 and FOXA1 expression in patients with hormone receptor-positive/HER2-negative breast cancer.

Hisamatsu Y, Tokunaga E, Yamashita N, Akiyoshi S, Okada S, Nakashima Y, Taketani K, Aishima S, Oda Y, Morita M, Maehara Y.

Breast Cancer. 2015 Sep;22(5):520-8. doi: 10.1007/s12282-013-0515-x. Epub 2014 Jan 11.

PMID:
24415069
24.

Differential impact of the expression of the androgen receptor by age in estrogen receptor-positive breast cancer.

Tokunaga E, Hisamatsu Y, Taketani K, Yamashita N, Akiyoshi S, Okada S, Tanaka K, Saeki H, Oki E, Aishima S, Oda Y, Morita M, Maehara Y.

Cancer Med. 2013 Dec;2(6):763-73. doi: 10.1002/cam4.138. Epub 2013 Sep 30.

25.

Luteinizing hormone-releasing hormone agonist plus an aromatase inhibitor as second-line endocrine therapy in premenopausal females with hormone receptor-positive metastatic breast cancer.

Tanaka K, Tokunaga E, Yamashita N, Taketani K, Akiyoshi S, Morita M, Maehara Y.

Surg Today. 2014 Sep;44(9):1678-84. doi: 10.1007/s00595-013-0765-4. Epub 2013 Nov 12.

PMID:
24218007
26.

Early discontinuation of adjuvant hormone therapy is associated with a poor prognosis in Japanese breast cancer patients.

Taketani K, Tokunaga E, Yamashita N, Tanaka K, Akiyoshi S, Okada S, Ando K, Kimura Y, Saeki H, Oki E, Morita M, Kusumoto T, Maehara Y.

Surg Today. 2014 Oct;44(10):1841-6. doi: 10.1007/s00595-013-0762-7. Epub 2013 Oct 19.

27.

Gene expression of bone morphogenic protein 8B in the primary site, peripheral blood and bone marrow of patients with gastric cancer.

Mima K, Fukagawa T, Kurashige J, Takano Y, Uchi R, Ueo H, Matsumura T, Ishibashi M, Sawada G, Takahashi Y, Akiyoshi S, Eguchi H, Sudo T, Sugimachi K, Watanabe M, Ishii H, Mori M, Baba H, Sasako M, Mimori K.

Oncol Lett. 2013 Aug;6(2):387-392. Epub 2013 Jun 12.

28.

Fatal hepatic hemorrhage by peliosis hepatis in X-linked myotubular myopathy: a case report.

Motoki T, Fukuda M, Nakano T, Matsukage S, Fukui A, Akiyoshi S, Hayashi YK, Ishii E, Nishino I.

Neuromuscul Disord. 2013 Nov;23(11):917-21. doi: 10.1016/j.nmd.2013.06.008. Epub 2013 Sep 4.

PMID:
24011703
29.

Loss of COP1 expression determines poor prognosisin patients with gastric cancer.

Sawada G, Ueo H, Matsumura T, Uchi R, Ishibashi M, Mima K, Kurashige J, Takahashi Y, Akiyoshi S, Sudo T, Sugimachi K, Doki Y, Mori M, Mimori K.

Oncol Rep. 2013 Oct;30(4):1971-5. doi: 10.3892/or.2013.2664. Epub 2013 Aug 8.

PMID:
23933908
30.

Microarray analysis reveals that high mobility group A1 is involved in colorectal cancer metastasis.

Takahashi Y, Sawada G, Sato T, Kurashige J, Mima K, Matsumura T, Uchi R, Ueo H, Ishibashi M, Takano Y, Akiyoshi S, Eguchi H, Sudo T, Sugimachi K, Tanaka J, Kudo SE, Doki Y, Mori M, Mimori K.

Oncol Rep. 2013 Sep;30(3):1488-96. doi: 10.3892/or.2013.2602. Epub 2013 Jul 8.

PMID:
23835740
31.

CHD8 is an independent prognostic indicator that regulates Wnt/β-catenin signaling and the cell cycle in gastric cancer.

Sawada G, Ueo H, Matsumura T, Uchi R, Ishibashi M, Mima K, Kurashige J, Takahashi Y, Akiyoshi S, Sudo T, Sugimachi K, Doki Y, Mori M, Mimori K.

Oncol Rep. 2013 Sep;30(3):1137-42. doi: 10.3892/or.2013.2597. Epub 2013 Jul 8.

PMID:
23835524
32.

Paired related homoeobox 1, a new EMT inducer, is involved in metastasis and poor prognosis in colorectal cancer.

Takahashi Y, Sawada G, Kurashige J, Uchi R, Matsumura T, Ueo H, Takano Y, Akiyoshi S, Eguchi H, Sudo T, Sugimachi K, Doki Y, Mori M, Mimori K.

Br J Cancer. 2013 Jul 23;109(2):307-11. doi: 10.1038/bjc.2013.339. Epub 2013 Jun 27.

33.

Tumor-derived tenascin-C promotes the epithelial-mesenchymal transition in colorectal cancer cells.

Takahashi Y, Sawada G, Kurashige J, Matsumura T, Uchi R, Ueo H, Ishibashi M, Takano Y, Akiyoshi S, Iwaya T, Eguchi H, Sudo T, Sugimachi K, Yamamoto H, Doki Y, Mori M, Mimori K.

Anticancer Res. 2013 May;33(5):1927-34.

PMID:
23645740
34.

Clinical significance of PICT1 in patients of hepatocellular carcinoma with wild-type TP53.

Ishibashi M, Kogo R, Shibata K, Ueo H, Uchi R, Matsumura T, Takano Y, Sawada G, Takahashi Y, Mima K, Kurashige J, Akiyoshi S, Iwaya T, Eguchi H, Sudo T, Sugimachi K, Suzuki A, Wakabayashi G, Mori M, Mimori K.

Ann Surg Oncol. 2013 Dec;20 Suppl 3:S537-44. doi: 10.1245/s10434-013-2958-x. Epub 2013 Mar 27.

PMID:
23532381
35.

Vimentin as a poor prognostic factor for triple-negative breast cancer.

Yamashita N, Tokunaga E, Kitao H, Hisamatsu Y, Taketani K, Akiyoshi S, Okada S, Aishima S, Morita M, Maehara Y.

J Cancer Res Clin Oncol. 2013 May;139(5):739-46. doi: 10.1007/s00432-013-1376-6. Epub 2013 Jan 26.

PMID:
23354842
36.

Clinical significance of the expression of long non-coding RNA HOTAIR in primary hepatocellular carcinoma.

Ishibashi M, Kogo R, Shibata K, Sawada G, Takahashi Y, Kurashige J, Akiyoshi S, Sasaki S, Iwaya T, Sudo T, Sugimachi K, Mimori K, Wakabayashi G, Mori M.

Oncol Rep. 2013 Mar;29(3):946-50. doi: 10.3892/or.2012.2219. Epub 2012 Dec 28.

PMID:
23292722
37.

Vascular endothelial growth factor receptor-1 mRNA overexpression in peripheral blood as a useful prognostic marker in breast cancer.

Kosaka Y, Kataoka A, Yamaguchi H, Ueo H, Akiyoshi S, Sengoku N, Kuranami M, Ohno S, Watanabe M, Mimori K, Mori M.

Breast Cancer Res. 2012 Oct 31;14(5):R140. doi: 10.1186/bcr3345.

38.

Laparoscopic surgery minimizes the surgical manipulation of isolated tumor cells leading to decreased metastasis compared to open surgery for colorectal cancer.

Akiyoshi S, Mimori K, Sudo T, Tanaka F, Shibata K, Mori M.

Surg Today. 2013 Jan;43(1):20-5. doi: 10.1007/s00595-012-0389-0. Epub 2012 Oct 27.

PMID:
23104554
39.

Clinical significance of miR-144-ZFX axis in disseminated tumour cells in bone marrow in gastric cancer cases.

Akiyoshi S, Fukagawa T, Ueo H, Ishibashi M, Takahashi Y, Fabbri M, Sasako M, Maehara Y, Mimori K, Mori M.

Br J Cancer. 2012 Oct 9;107(8):1345-53. doi: 10.1038/bjc.2012.326. Epub 2012 Sep 6.

40.

Overexpression of metadherin/MTDH is associated with an aggressive phenotype and a poor prognosis in invasive breast cancer.

Tokunaga E, Nakashima Y, Yamashita N, Hisamatsu Y, Okada S, Akiyoshi S, Aishima S, Kitao H, Morita M, Maehara Y.

Breast Cancer. 2014 May;21(3):341-9. doi: 10.1007/s12282-012-0398-2. Epub 2012 Aug 18.

PMID:
22903204
42.

Loss of heterozygosity at BRCA1 locus is significantly associated with aggressiveness and poor prognosis in breast cancer.

Okada S, Tokunaga E, Kitao H, Akiyoshi S, Yamashita N, Saeki H, Oki E, Morita M, Kakeji Y, Maehara Y.

Ann Surg Oncol. 2012 May;19(5):1499-507. doi: 10.1245/s10434-011-2166-5. Epub 2011 Dec 17.

PMID:
22179631
43.

Impact of FOXA1 expression on the prognosis of patients with hormone receptor-positive breast cancer.

Hisamatsu Y, Tokunaga E, Yamashita N, Akiyoshi S, Okada S, Nakashima Y, Aishima S, Morita M, Kakeji Y, Maehara Y.

Ann Surg Oncol. 2012 Apr;19(4):1145-52. doi: 10.1245/s10434-011-2094-4. Epub 2011 Oct 8.

PMID:
21984487
44.

High incidence and frequency of LOH are associated with aggressive features of high-grade HER2 and triple-negative breast cancers.

Tokunaga E, Okada S, Yamashita N, Akiyoshi S, Kitao H, Morita M, Kakeji Y, Maehara Y.

Breast Cancer. 2012 Apr;19(2):161-9. doi: 10.1007/s12282-010-0232-7. Epub 2010 Nov 10.

PMID:
21063923
45.

Targets of transcriptional regulation by transforming growth factor-beta: expression profile analysis using oligonucleotide arrays.

Akiyoshi S, Ishii M, Nemoto N, Kawabata M, Aburatani H, Miyazono K.

Jpn J Cancer Res. 2001 Mar;92(3):257-68.

46.

Reduction of carotid arterial blood flow in ventricular septal defect associated with severe congestive heart failure.

Kojo M, Yamada K, Akiyoshi S, Maeda M, Sato K, Izumi T.

J Neuroimaging. 2000 Oct;10(4):241-3.

PMID:
11147409
47.

[Diagnostic accuracy of carotid ultrasonography in screening for coronary artery disease].

Kawasaki T, Koga N, Hikichi Y, Otsubo Y, Kondo K, Shiraishi T, Watanabe T, Higashikata T, Akiyoshi S, Kurashige Y.

J Cardiol. 2000 Nov;36(5):295-302. Japanese.

PMID:
11107551
48.

A genetic linkage map of the MSM Japanese wild mouse strain with restriction landmark genomic scanning (RLGS).

Akiyoshi S, Kanda H, Okazaki Y, Akama T, Nomura K, Hayashizaki Y, Kitagawa T.

Mamm Genome. 2000 May;11(5):356-9.

PMID:
10790533
49.

c-Ski acts as a transcriptional co-repressor in transforming growth factor-beta signaling through interaction with smads.

Akiyoshi S, Inoue H, Hanai J, Kusanagi K, Nemoto N, Miyazono K, Kawabata M.

J Biol Chem. 1999 Dec 3;274(49):35269-77.

50.

Application of the RLGS image analysis tool (RAT) to the construction of a genetic linkage map of recombinant inbred strain SMXA.

Sugahara Y, Akiyoshi S, Okazaki Y, Tanihata I, Hayashizaki Y, Nishimura M.

Mamm Genome. 1999 Jun;10(6):611-6. Erratum in: Mamm Genome 1999 Nov;10(11):1117.

PMID:
10341096

Supplemental Content

Loading ...
Support Center